IL10 and inflammatory bowel disease: Although relatively few clinical trials have explored the use of NPs in IBD treatment, their effects under animal experiments, including in IL-10 deficient, dinitrobenzene sulfonic acid (DNBS), trinitrobenzene sulfonic acid (TNBS), and dextran sulfate sodium salt (DSS)-induced IBD mice models, have been investigated extensively [26].